NDC 68999-803-05 - Acyclovir
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 68999-803
- Requested NDC
- 68999-803-05
- Package NDCs from labels
- 68999-803-05, 68999-803-24, 68999-803-20, 68999-803-23
- Manufacturer
- Chartwell Governmental & Specialty RX, LLC.
- Effective date
- 2025-12-23
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Acyclovir Oral Suspension, USP Rx only | Chartwell Governmental & Specialty RX, LLC. | 2025-12-23 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68999-803-05 | Acyclovir | 5 mL in 1 CUP | SUSPENSION | 5 | 1 | |
| 68999-803-20 | Acyclovir | 20 mL in 1 CUP | SUSPENSION | 20 | 1 | |
| 68999-803-23 | Acyclovir | 10 in 1 TRAY | SUSPENSION | 10 | 1 | |
| 68999-803-23 | Acyclovir | 2 in 1 BOX | SUSPENSION | 2 | 1 | |
| 68999-803-24 | Acyclovir | 10 in 1 TRAY | SUSPENSION | 10 | 1 | |
| 68999-803-24 | Acyclovir | 2 in 1 BOX | SUSPENSION | 2 | 1 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 68999-803-05 | ML - Milliliter | 68999-803 | 271b8197-8986-496b-94d1-d1ae4d55f7f0 | 1 | 2026-03-17 |
| 68999-803-20 | ML - Milliliter | 68999-803 | ef914da3-9819-4c70-8dc5-4fd2bf99caed | 1 | 2026-03-17 |
| 68999-803-23 | ML - Milliliter | 68999-803 | eb160a02-2ca1-4529-96e7-e23af5e36cc4 | 1 | 2026-03-17 |
| 68999-803-24 | ML - Milliliter | 68999-803 | 4602e8cc-7e17-4e4b-b24f-c95396d1dfd1 | 1 | 2026-03-17 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| TheraTears | CARBOXYMETHYLCELLULOSE SODIUM | MEDTECH PRODUCTS INC | 17a01236-130f-495b-9f8d-92b6a23b2dc5 | 2026-09-09 | Warnings | K679OBS311 |
| Leader Eye Drops Redness Relief | GLYCERIN, NAPHAZOLINE HYDROCHLORIDE | Cardinal Health | aee4bbe2-4f11-4c54-be8b-df48b3ba4f3a | 2026-09-09 | Warnings | PDC6A3C0OX |
| Hemorrhoidal | GLYCERIN, PHENYLEPHRINE HCL, PRAMOXINE HCL, WHITE PETROLATUM | Rite Aid Corporation | 407c78ca-6fee-4ed6-b61b-711ec049c86e | 2026-09-09 | Warnings | PDC6A3C0OX |
| Clear Eyes Nighttime | GLYCERIN | Prestige Brands Holdings, Inc. | af75e2f7-81dd-43e0-a390-b52bbfbebf62 | 2026-09-08 | Warnings | PDC6A3C0OX |
| Hemorrhoidal | GLYCERIN, PHENYLEPHRINE HCL, PRAMOXINE HCL, WHITE PETROLATUM | CVS Pharmacy | 3167c918-a7d3-46a1-a85b-64f9c22916f2 | 2026-09-04 | Warnings | PDC6A3C0OX |
| ACYCLOVIR | ACYCLOVIR | REMEDYREPACK INC. | c1744e01-0e40-4851-8ffc-c3bf29dd7c2b | 2026-08-31 | Warnings, Adverse reactions | X4HES1O11F |
| REFRESH LIQUIGEL | CARBOXYMETHYLCELLULOSE SODIUM | Allergan, Inc. | 4b8b2f6a-4b89-446c-9e5b-9b83c453a01d | 2026-08-28 | Warnings | K679OBS311 |
| Acyclovir | ACYCLOVIR | NuCare Pharmaceuticals, Inc. | 5176c7f9-9076-4797-e054-00144ff8d46c | 2026-08-27 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | NuCare Pharmaceuticals,Inc. | e5e99a6b-79a6-7fdb-e053-2a95a90a8563 | 2026-08-26 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | PD-Rx Pharmaceuticals, Inc. | 58dc1402-6098-9cb3-e063-6294a90a062b | 2026-08-19 | Warnings, Adverse reactions | X4HES1O11F |
| acyclovir | ACYCLOVIR | Northwind Health Company, LLC | 50c58161-3944-7367-e063-6394a90a6286 | 2026-08-19 | Warnings, Adverse reactions | X4HES1O11F |
| Leader Dry Eye Relief Eye Drops | GLYCERIN, HYPROMELLOSE, POLYETHYLENE GLYCOL 400 | CARDINAL HEALTH 110, LLC. DBA LEADER | 2ded4bda-b3c3-4521-8701-5c8446fd148b | 2026-08-17 | Warnings | PDC6A3C0OX |
| BM BM164 DROPS | ARUM TRYPH, CAUSTICUM, BALSAMUM PERU, HELONIAS DIO, ACID PHOS, GLYCERINUM, EQUISETUM | BM Private Limited | 5902770f-eb01-d099-e063-6394a90ad3eb | 2026-08-14 | Warnings | PDC6A3C0OX |
| ACYCLOVIR | ACYCLOVIR | Cardinal Health 107, LLC | 4cc7d67f-35fa-4238-a581-4810645083cf | 2026-08-13 | Warnings, Adverse reactions | X4HES1O11F |
| acyclovir | ACYCLOVIR | c | 59007780-d736-4195-a204-7f85a709ed46 | 2026-08-12 | Warnings, Adverse reactions | X4HES1O11F |
| CVS Glycerin | GLYCERIN SUPPOISITORY | CVS Pharmacy, Inc | ca6d13db-60e8-4fcc-b7b3-3eb280b8c435 | 2026-08-04 | Warnings | PDC6A3C0OX |
| Topwin Speedy Enema | GLYCERIN | Health Chemical Pharmaceutical Co., Ltd | 3ba8c3d2-1780-42e1-bec5-8f98771d475e | 2026-07-27 | Warnings | PDC6A3C0OX |
| ACYCLOVIR | ACYCLOVIR | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 0de2f5c7-9e75-4bdf-9c28-e026cc6694b4 | 2026-07-24 | Warnings, Adverse reactions | X4HES1O11F |
| acyclovir | ACYCLOVIR | PD-Rx Pharmaceuticals, Inc. | 86c43bdf-c5bf-47cd-8dfd-811263825878 | 2026-07-24 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | REMEDYREPACK INC. | 6d0e492e-5359-49e8-812d-8c8e2e5d42f8 | 2026-07-24 | Warnings, Adverse reactions | X4HES1O11F |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.